Zika virus-an update on the current efforts for vaccine development.
Ontology highlight
ABSTRACT: In 2015, the world witnessed the resurgence and global spread of Zika virus (ZIKV). This arbovirus infection is associated with Guillain-Barré syndrome in adults and with devastating congenital malformations during pregnancy. Despite scientific efforts, the development of a vaccine capable of inducing long-term protection has been challenging. Without a safe and efficacious licensed vaccine, control of virus transmission is based on vector control, but this strategy has been shown to be inefficient. An effective and protective vaccine relies on several requirements, which include: (i) induction of specific immune response against immunodominant antigens; (ii) selection of adjuvant-antigen formulation; and (iii) assessment of safety, effectiveness, and long-term protection. In this commenta
SUBMITTER: Lunardelli VAS
PROVIDER: S-EPMC7993142 | biostudies-literature | 2021 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA